Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
28,417,218
Total 13F shares
375,681
Share change
-19,680
Total reported value
$2,553,139
Put/Call ratio
23%
Price per share
$6.80
Number of holders
10
Value change
-$131,129
Number of buys
2
Number of sells
10

Institutional Holders of ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) as of Q1 2024

As of 31 Mar 2024, ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 375,681 shares. The largest 10 holders included MORGAN STANLEY, CITADEL ADVISORS LLC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, Bank of New York Mellon Corp, DEUTSCHE BANK AG\, JPMORGAN CHASE & CO, CoreCap Advisors, LLC, Legal & General Group Plc, Royal Bank of Canada, and NEW YORK STATE COMMON RETIREMENT FUND. This page lists 12 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.